Evidence map›Paper›PMID 42792085›Full record

ReviewAntibiotics (Basel, Switzerland)2026

Risk-Stratified Effectiveness of Cephamycins Versus Carbapenems for ESBL-Producing

Giacomo Franceschi, Mattia Marchi, Samuele Cantergiani, Gabriella Orlando, Stefania Casolari, Erica Franceschini, Andrea Bedini, Cristina Mussini, Marianna Meschiari

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giacomo FranceschiDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0003-0047-6634
Mattia MarchiDepartment of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0003-2970-1276
Samuele CantergianiDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Gabriella OrlandoDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Stefania CasolariDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0003-2494-464X
Erica FranceschiniDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0001-6922-5759
Andrea BediniDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0002-4041-1459
Cristina MussiniDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Marianna MeschiariDepartment of Infectious Diseases, Azienda Ospedaliera-Universitaria of Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial stewardshipbloodstream infectioncarbapenemscephamycinsEscherichia coliextended-spectrum β-lactamaseKlebsiella pneumoniaemeta-analysisurinary tract infection

Identifiers

PMID42792085
PMCPMC13603874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.